H2304 study investigators are listed in the Appendix.
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
Article first published online: 6 AUG 2012
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 12, Issue 11, pages 3008–3020, November 2012
How to Cite
De Simone, P., Nevens, F., De Carlis, L., Metselaar, H. J., Beckebaum, S., Saliba, F., Jonas, S., Sudan, D., Fung, J., Fischer, L., Duvoux, C., Chavin, K. D., Koneru, B., Huang, M. A., Chapman, W. C., Foltys, D., Witte, S., Jiang, H., Hexham, J. M., Junge, G. and for the H2304 Study Group (2012), Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial. American Journal of Transplantation, 12: 3008–3020. doi: 10.1111/j.1600-6143.2012.04212.x
Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
- Issue published online: 27 OCT 2012
- Article first published online: 6 AUG 2012
- Received 03 April 2012, revised 21 May 2012 and accepted for publication 12 June 2012
Supporting Methods: Study design and conduct, patients, randomization, intervention and concomitant medication, study endpoints, statistical analysis.
Figure S1: Tacrolimus trough concentration from randomization to month 12 posttransplant (safety population). Values are shown as mean (SD).
|AJT_4212_sm_FigS1.pdf||127K||Supporting info item|
|AJT_4212_sm_Methods.doc||33K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.